FDA NDC Directory · JSON-LD · Markdown

Arixtra

NDC 67457-593 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namefondaparinux sodium
Labeler / ManufacturerMylan Institutional LLC
Marketing categoryNew Drug Application (innovator) · App NDA021345
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsFONDAPARINUX SODIUM (5 mg/.4mL)
Marketing started20140519
Package count1

External sources

Source: openFDA. Public-domain (CC0).